Clinical Trial Update: Immune Cells as a New Biomarker of Response in Patients Treated by Immunotherapy for Advanced Hepatocellular Carcinoma

View source ↗

Summary

A clinical trial update reports that immune cell biomarkers may predict responses to immunotherapy in advanced hepatocellular carcinoma; the study has been term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Hepatocellular Carcinoma | Status: TERMINATED